249 related articles for article (PubMed ID: 17486587)
1. Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma.
Wu TT; Hsieh YH; Hsieh YS; Liu JY
J Cell Biochem; 2008 Jan; 103(1):9-20. PubMed ID: 17486587
[TBL] [Abstract][Full Text] [Related]
2. Constitutive production of colony-stimulating factors by human hepatoma cell lines: possible correlation with cell differentiation.
Wang SY; Chen LY; Tsai TF; Su TS; Choo KB; Ho CK
Exp Hematol; 1996 Feb; 24(3):437-44. PubMed ID: 8599973
[TBL] [Abstract][Full Text] [Related]
3. Antisense oligonucleotide Elk-1 suppresses the tumorigenicity of human hepatocellular carcinoma cells.
Ying TH; Hsieh YH; Hsieh YS; Liu JY
Cell Biol Int; 2008 Feb; 32(2):210-6. PubMed ID: 17950002
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of cyclin D1 expression in asthma serum-sensitized human airway smooth muscle promotes proliferation via protein kinase C alpha.
Du CL; Xu YJ; Liu XS; Xie JG; Xie M; Zhang ZX; Zhang J; Qiao LF
Exp Lung Res; 2010 May; 36(4):201-10. PubMed ID: 20426528
[TBL] [Abstract][Full Text] [Related]
5. Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels.
Baiz D; Pozzato G; Dapas B; Farra R; Scaggiante B; Grassi M; Uxa L; Giansante C; Zennaro C; Guarnieri G; Grassi G
Biochimie; 2009 Mar; 91(3):373-82. PubMed ID: 19041685
[TBL] [Abstract][Full Text] [Related]
6. Involvement of protein kinase C beta-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion.
Guo K; Liu Y; Zhou H; Dai Z; Zhang J; Sun R; Chen J; Sun Q; Lu W; Kang X; Chen P
Cancer Sci; 2008 Mar; 99(3):486-96. PubMed ID: 18167130
[TBL] [Abstract][Full Text] [Related]
7. Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors.
Tan M; Li P; Sun M; Yin G; Yu D
Oncogene; 2006 Jun; 25(23):3286-95. PubMed ID: 16407820
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of antioxidant enzymes in various hepatocellular carcinoma cell lines.
Yang LY; Chen WL; Lin JW; Lee SF; Lee CC; Hung TI; Wei YH; Shih CM
J Cell Biochem; 2005 Oct; 96(3):622-31. PubMed ID: 16052474
[TBL] [Abstract][Full Text] [Related]
9. p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells.
Hsieh YH; Wu TT; Huang CY; Hsieh YS; Hwang JM; Liu JY
Cancer Res; 2007 May; 67(9):4320-7. PubMed ID: 17483345
[TBL] [Abstract][Full Text] [Related]
10. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; Croce CM; Tavolari S; Chieco P; Negrini M; Bolondi L
Cancer Res; 2009 Jul; 69(14):5761-7. PubMed ID: 19584283
[TBL] [Abstract][Full Text] [Related]
11. Increase of Bax/ Bcl-XL ratio and arrest of cell cycle by luteolin in immortalized human hepatoma cell line.
Chang J; Hsu Y; Kuo P; Kuo Y; Chiang L; Lin C
Life Sci; 2005 Mar; 76(16):1883-93. PubMed ID: 15698865
[TBL] [Abstract][Full Text] [Related]
12. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
13. CDC25A inhibition suppresses the growth and invasion of human hepatocellular carcinoma cells.
Xu X; Yamamoto H; Liu G; Ito Y; Ngan CY; Kondo M; Nagano H; Dono K; Sekimoto M; Monden M
Int J Mol Med; 2008 Feb; 21(2):145-52. PubMed ID: 18204780
[TBL] [Abstract][Full Text] [Related]
14. The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells.
Lampiasi N; Foderà D; D'Alessandro N; Cusimano A; Azzolina A; Tripodo C; Florena AM; Minervini MI; Notarbartolo M; Montalto G; Cervello M
Int J Mol Med; 2006 Feb; 17(2):245-52. PubMed ID: 16391822
[TBL] [Abstract][Full Text] [Related]
15. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L
Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
[TBL] [Abstract][Full Text] [Related]
16. [nm23-H1 gene inhibits lung cancer cell invasion through down-regulation of PKC signal pathway].
Nie Q; Zhou QH; Zhu W; Liu LX; Fu JK; Li DB; Li Y; Che GW
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):334-6. PubMed ID: 17044994
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
[TBL] [Abstract][Full Text] [Related]
18. PKCalpha expression regulated by Elk-1 and MZF-1 in human HCC cells.
Hsieh YH; Wu TT; Tsai JH; Huang CY; Hsieh YS; Liu JY
Biochem Biophys Res Commun; 2006 Jan; 339(1):217-25. PubMed ID: 16297876
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of transcriptional coactivator AIB1 promotes hepatocellular carcinoma progression by enhancing cell proliferation and invasiveness.
Xu Y; Chen Q; Li W; Su X; Chen T; Liu Y; Zhao Y; Yu C
Oncogene; 2010 Jun; 29(23):3386-97. PubMed ID: 20305690
[TBL] [Abstract][Full Text] [Related]
20. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]